-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Total costs of sales and operating expenses for the period.
-
Summary
-
Aerie Pharmaceuticals Inc quarterly/annual Costs and Expenses history and growth rate from Q1 2017 to Q3 2022.
- Aerie Pharmaceuticals Inc Costs and Expenses for the quarter ending September 30, 2022 was $62.8M, a 1.81% increase year-over-year.
- Aerie Pharmaceuticals Inc Costs and Expenses for the twelve months ending September 30, 2022 was $241M, a 1.18% increase year-over-year.
- Aerie Pharmaceuticals Inc annual Costs and Expenses for 2021 was $240M, a 0.7% increase from 2020.
- Aerie Pharmaceuticals Inc annual Costs and Expenses for 2020 was $239M, a 7.21% decline from 2019.
- Aerie Pharmaceuticals Inc annual Costs and Expenses for 2019 was $257M, a 10% increase from 2018.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Quarterly (USD)
Costs and Expenses, YoY Quarterly Growth (%)